ArticleJournal of thoracic disease2018
Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial.
Peter L Thompson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this papercites it